Jolley Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Jolley Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,292	Closed	-$127K	–	76
2018 Q2	$127K	Hold	2,292	–	–	0.09%	83
2018 Q1	$145K	Hold	2,292	–	–	0.09%	74
2017 Q4	$140K	Hold	2,292	–	–	0.09%	74
2017 Q3	$146K	Hold	2,292	–	–	0.1%	72
2017 Q2	$128K	Hold	2,292	–	–	0.09%	77
2017 Q1	$125K	Hold	2,292	–	–	0.09%	71
2016 Q4	$134K	Hold	2,292	–	–	0.1%	68
2016 Q3	$124K	Buy	2,292 +200	+10%	+$12.8K	0.1%	67
2016 Q2	$154K	Buy	2,092 +80	+4%	+$5.65K	0.12%	63
2016 Q1	$129K	Buy	2,012 +1,150	+133%	+$72.5K	0.12%	56
2015 Q4	$59K	Sell	862 -30	-3%	-$1.98K	0.06%	69
2015 Q3	$53K	Hold	892	–	–	0.05%	68
2015 Q2	$59K	Sell	892 -10	-1%	-$659	0.05%	67
2015 Q1	$58K	Hold	902	–	–	0.05%	67
2014 Q4	$53K	Hold	902	–	–	0.04%	73
2014 Q3	$46K	Sell	902 -30	-3%	-$1.5K	0.04%	77
2014 Q2	$45K	Hold	932	–	–	0.03%	85
2014 Q1	$48K	Hold	932	–	–	0.04%	77
2013 Q4	$50K	Buy	932 +105	+13%	+$5.35K	0.04%	72
2013 Q3	$38K	Hold	827	–	–	0.03%	80
2013 Q2	$37K	Buy	+827	New	+$35.9K	0.03%	78

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jolley Asset Management's BMY Position: Q3 2018 in Review

Jolley Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 2,292 shares — an estimated $127K sold.

Jolley Asset Management first reported a position in BMY in Q2 2013 and held it in 21 quarters. The position peaked at $154K in Q2 2016. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Jolley Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
Jolley Asset Management sold 2,292 Bristol-Myers Squibb shares in Q3 2018, an estimated $127K.
Jolley Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 21 quarters.
Jolley Asset Management's Bristol-Myers Squibb position peaked at $154K in Q2 2016.
1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Jolley Asset Management's 13F filing for Q3 2018, filed 18 Oct 2018.